Lululemon kicked off 2026 under pressure after issuing revenue and profit guidance that disappointed Wall Street analysts and announcing a high-profile board shakeup amid an ongoing proxy fight from company founder Chip Wilson.
The athletic apparel giant projected full-year revenue between $11.35 billion and $11.50 billion, coming in below the analyst consensus of $11.52 billion. Earnings per share guidance of $12.10 to $12.30 also trailed expectations of $12.58. Despite the cautious outlook, analysts noted the conservative guidance may reflect the absence of a permanent CEO following Calvin McDonald's exit in January, with the company currently being led by interim co-CEO and CFO Meghan Frank.
Frank emphasized that restoring full-price sales growth in North America is a top priority, pointing to plans around refreshing product designs, trimming excess inventory, and reducing markdowns. Lululemon also stated it expects to offset nearly all of the estimated $380 million gross impact from U.S. import tariffs — a notable increase from $275 million in 2025 — as it diversifies its sourcing strategy away from heavy reliance on China.
On the governance front, Lululemon named former Levi Strauss CEO Chip Bergh to its board of directors, a move that drew praise from industry analysts who cited his turnaround experience in apparel. Meanwhile, longtime board member David Mussafer announced he would not seek re-election, a development seen as a partial concession amid Wilson's ongoing push for structural board changes.
Wilson, who controls roughly 4.27% of company shares, has nominated three independent directors and called for annual board elections, citing concerns over conflicts of interest in the CEO search process.
Lululemon's stock slipped around 1.5% in after-hours trading and has declined approximately 23% year-to-date, reflecting broader headwinds from intensifying competition, shifting consumer sentiment, and uncertainty surrounding long-term brand leadership.


Samsung Union Talks Enter Final Stage as Strike Threat Looms
Sonova Beats Profit Forecasts Despite Cochlear Implant Weakness
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Samsung Faces Major Strike Threat as Union Restarts Pay Talks
CXMT Forecasts Record Revenue Growth as Global DRAM Prices Surge
Alphabet Raises Record $3.6 Billion in Yen Bonds to Support AI Expansion
OpenAI Wins Elon Musk Lawsuit as Jury Rejects Claims Over AI Mission
US-China Trade Talks Sideline Chip Export Controls as Nvidia China Sales Draw Attention
Thyssenkrupp to Shut Down Indiana Automotive Plant by March 2026
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Anthropic Nears $30 Billion Funding Round at $900 Billion Valuation
Honda Shares Jump as Automaker Forecasts Profit Recovery Despite Historic Loss
Samsung Shares Drop as Labor Union Confirms Planned Strike
Applied Materials Forecasts Strong Q3 Revenue as AI Chip Demand Accelerates
Elliott Targets Bio-Rad as Shares Continue to Struggle
Berkshire Hathaway Reveals New Stakes in Delta Air Lines and Macy’s Under Greg Abel 



